Charles River Laboratories International Inc (NYSE: CRL) and Autobahn Labs, a virtual accelerator backed by Samsara BioCapital, on Wednesday announced a collaborative agreement to expedite the translation of academic discoveries into novel therapeutics. This partnership positions Charles River as the preferred research partner for Autobahn Labs, offering access to Charles River's comprehensive drug discovery and development capabilities.
As part of the agreement, Charles River has made an equity investment in Autobahn Labs, participating in a fundraising round led by Samsara BioCapital. This investment aims to expand Autobahn's partnerships with top-tier academic institutions, advance preclinical programs, and identify new therapeutic opportunities. Additionally, Justin Bryans, chief scientific officer of Discovery at Charles River, has joined Autobahn's board of directors.
Autobahn Labs, founded in 2019 by Samsara BioCapital, collaborates with leading research institutions to accelerate the development of new therapies, leveraging intellectual, financial and physical capital to transform scientific hypotheses into novel drug candidates.
Charles River provides essential services to pharmaceutical and biotechnology companies, government agencies and academic institutions worldwide, facilitating research and development of new therapies for patients.
Indivior updates on Aelis Farma's Phase 2B study of AEF0117 for Cannabis Use Disorder
Vesper Bio announces positive Phase I results for FTD treatment
Empower Pharmacy names new president
Innovent's IBI363 receives US FDA Fast Track Designation
Valneva and Pfizer report positive Phase 2 booster results for Lyme disease vaccine
Grit Biotechnology's GT201 receives US FDA IND approval
Cereno Scientific doses first patient in Expanded Access Program for PAH
Medicilon USA begins operations at second R&D centre in Massachusetts
CS Genetics names new chief operating officer and chief scientific officer
Expanse Medical names new chief executive officer and FlowPhysix board member